Literature DB >> 33540617

ERK-Directed Phosphorylation of mGlu5 Gates Methamphetamine Reward and Reinforcement in Mouse.

Elissa K Fultz1, Sema G Quadir1, Douglas Martin1, Daniel M Flaherty1, Paul F Worley2, Tod E Kippin1,3,4, Karen K Szumlinski1,3.   

Abstract

Methamphetamine (MA) is a highly addictive psychomotor stimulant drug. In recent years, MA use has increased exponentially on a global scale, with the number of MA-involved deaths reaching epidemic proportions. There is no approved pharmacotherapy for treating MA use disorder, and we know relatively little regarding the neurobiological determinants of vulnerability to this disease. Extracellular signal-regulated kinase (ERK) is an important signaling molecule implicated in the long-lasting neuroadaptations purported to underlie the development of substance use disorders, but the role for this kinase in the propensity to develop addiction, particularly MA use disorder, is uncharacterized. In a previous MA-induced place-conditioning study of C57BL/6J mice, we characterized mice as MA-preferring, -neutral, or -avoiding and collected tissue from the medial prefrontal cortex (mPFC). Using immunoblotting, we determined that elevated phosphorylated ERK expression within the medial prefrontal cortex (mPFC) is a biochemical correlate of the affective valence of MA in a population of C57BL/6J mice. We confirmed the functional relevance for mPFC ERK activation for MA-induced place-preference via site-directed infusion of the MEK inhibitor U0126. By contrast, ERK inhibition did not have any effect upon MA-induced locomotion or its sensitization upon repeated MA treatment. Through studies of transgenic mice with alanine point mutations on T1123/S1126 of mGlu5 that disrupt ERK-dependent phosphorylation of the receptor, we discovered that ERK-dependent mGlu5 phosphorylation normally suppresses MA-induced conditioned place-preference (MA-CPP), but is necessary for this drug's reinforcing properties. If relevant to humans, the present results implicate individual differences in the capacity of MA-associated cues/contexts to hyper-activate ERK signaling within mPFC in MA Use Disorder vulnerability and pose mGlu5 as one ERK-directed target contributing to the propensity to seek out and take MA.

Entities:  

Keywords:  addiction; metabotropic glutamate receptor 5; methamphetamine; place-conditioning; reinforcement; self-administration; vulnerability

Mesh:

Substances:

Year:  2021        PMID: 33540617      PMCID: PMC7867251          DOI: 10.3390/ijms22031473

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  72 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

2.  Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.

Authors:  Karen K Szumlinski; Kevin D Lominac; Rianne R Campbell; Matan Cohen; Elissa K Fultz; Chelsea N Brown; Bailey W Miller; Sema G Quadir; Douglas Martin; Andrew B Thompson; Georg von Jonquieres; Matthias Klugmann; Tamara J Phillips; Tod E Kippin
Journal:  Biol Psychiatry       Date:  2016-10-13       Impact factor: 13.382

3.  Regulatory effect of bee venom on methamphetamine-induced cellular activities in prefrontal cortex and nucleus accumbens in mice.

Authors:  Ji Seon Son; Young Chan Jeong; Young Bae Kwon
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

4.  Variability in subjective responses to cocaine: initial experiences of college students.

Authors:  E S Davidson; J F Finch; S Schenk
Journal:  Addict Behav       Date:  1993 Jul-Aug       Impact factor: 3.913

5.  Prior binge-drinking history promotes the positive affective valence of methamphetamine in mice.

Authors:  Elissa K Fultz; Karen K Szumlinski
Journal:  Drug Alcohol Depend       Date:  2017-12-11       Impact factor: 4.492

6.  Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.

Authors:  Hongliang Su; Tingting Sun; Xiao Wang; Yan Du; Na Zhao; Jie Zhu; Jiangwei Yan; Teng Chen; Keming Yun
Journal:  Neurosci Lett       Date:  2019-08-06       Impact factor: 3.046

7.  Prefrontal glutamate correlates of methamphetamine sensitization and preference.

Authors:  Kevin D Lominac; Sema G Quadir; Hannah M Barrett; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Rianne R Campbell; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tod E Kippin; Tamara J Phillips; Karen K Szumlinski
Journal:  Eur J Neurosci       Date:  2016-02-22       Impact factor: 3.386

8.  Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats.

Authors:  Todor V Gerdjikov; Gregory M Ross; Richard J Beninger
Journal:  Behav Neurosci       Date:  2004-08       Impact factor: 1.912

9.  Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse.

Authors:  Joseph O'Neill; Marc C Tobias; Matthew Hudkins; Edythe D London
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

10.  Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.

Authors:  Chris-Ellyn Johanson; Kirk A Frey; Leslie H Lundahl; Pamela Keenan; Nancy Lockhart; John Roll; Gantt P Galloway; Robert A Koeppe; Michael R Kilbourn; Trevor Robbins; Charles R Schuster
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

View more
  1 in total

Review 1.  Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update.

Authors:  Li-Min Mao; Alaya Bodepudi; Xiang-Ping Chu; John Q Wang
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.